Philip Barth, MD

Sr. Consultant, Clinical Operations
Allecra Therapeutics SAS

Disclosure: Allecra Therapeutics SAS (Consultant)

Presentation(s):

• LB-4 - Cefepime-Enmetazobactam Demonstrates Superiority to Piperacillin-Tazobactam in a Subgroup of Patients with Complicated Urinary Tract Infections/Acute Pyelonephritis Caused by Extended Spectrum β-Lactamase-Producing Enterobacterales

  Saturday, October 24, 2020
  10:20am – 10:30am EDT